Cepheid, American Lung Association partner to promote TB awareness in U.S.

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Jul 23 2013Cepheid

Cepheid (Nasdaq: CPHD) and the American Lung Association (www.Lung.org) today announced a partnership to promote tuberculosis-related awareness in the U.S. and the need for improved TB (tuberculosis) diagnostics. Details of the planned program will be announced at the American Association of Clinical Chemistry and Clinical Lab Expo show in Houston, Texas. The live announcement will take place at 10am on July 30th at Cepheid booth #4529.

As part of the program to highlight the need for increased public awareness and education for TB in the U.S., Paul Teutul Jr. and his team at Paul Jr. Designs (www.pauljrdesigns.com), will unveil a brand new creation live during the announcement. Complete details on the program will be disclosed during the event at Cepheid booth #4529. 

The live unveil and announcement is open to all show attendees. Those not attending the show in Houston can read the details of the program in an expected simultaneous press release.

Source:

Cepheid

Posted in: Disease/Infection News | Healthcare News

Tags: , , , , , , , ,

Comments (0)

Suggested Reading

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines
Redefining tuberculosis classification to enhance early detection and treatment
Study reveals lasting lung damage in tuberculosis survivors
Mtb bacteria detected in exhaled breath of 90% of individuals presenting with suspected tuberculosis
The path to a better tuberculosis vaccine runs through Montana
WHO releases an investment case for TB screening and preventive treatment
New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis
Leveraging cancer therapies to combat tuberculosis

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Enzymatic cocktail emerges as new hope against mycobacterial infections